| Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study KM Musallam, HM Tamim, T Richards, DR Spahn, FR Rosendaal, ... The Lancet 378 (9800), 1396-1407, 2011 | 1401 | 2011 |
| Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management MD Cappellini, J Comin‐Colet, A de Francisco, A Dignass, W Doehner, ... American journal of hematology 92 (10), 1068-1078, 2017 | 498 | 2017 |
| Iron deficiency anaemia revisited MD Cappellini, KM Musallam, AT Taher Journal of internal medicine 287 (2), 153-170, 2020 | 493 | 2020 |
| Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders F Peyvandi, R Palla, M Menegatti, SM Siboni, S Halimeh, B Faeser, ... Journal of Thrombosis and Haemostasis 10 (4), 615-621, 2012 | 470 | 2012 |
| Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study AT Taher, KM Musallam, M Karimi, A El-Beshlawy, K Belhoul, S Daar, ... Blood, The Journal of the American Society of Hematology 115 (10), 1886-1892, 2010 | 459 | 2010 |
| Non-transfusion-dependent thalassemias KM Musallam, S Rivella, E Vichinsky, EA Rachmilewitz haematologica 98 (6), 833, 2013 | 361 | 2013 |
| Guidelines for the management of non transfusion dependent thalassaemia (NTDT) A Taher, E Vichinsky, K Musallam, MD Cappellini, V Viprakasit | 287 | 2014 |
| Optimal management of β thalassaemia intermedia AT Taher, KM Musallam, MD Cappellini, DJ Weatherall British journal of haematology 152 (5), 512-523, 2011 | 270 | 2011 |
| β-Thalassemias AT Taher, KM Musallam, MD Cappellini New England Journal of Medicine 384 (8), 727-743, 2021 | 251 | 2021 |
| Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia KM Musallam, AT Taher, MD Cappellini, VG Sankaran Blood, The Journal of the American Society of Hematology 121 (12), 2199-2212, 2013 | 240 | 2013 |
| Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia KM Musallam, MD Cappellini, JC Wood, I Motta, G Graziadei, H Tamim, ... Haematologica 96 (11), 1605, 2011 | 225 | 2011 |
| Bone disease and skeletal complications in patients with β thalassemia major R Haidar, KM Musallam, AT Taher Bone 48 (3), 425-432, 2011 | 186 | 2011 |
| β-thalassemia intermedia: a clinical perspective KM Musallam, AT Taher, EA Rachmilewitz Cold Spring Harbor perspectives in medicine 2 (7), a013482, 2012 | 176 | 2012 |
| Splenectomy and thrombosis: the case of thalassemia intermedia AT Taher, KM Musallam, M Karimi, A El‐Beshlawy, K Belhoul, S Daar, ... Journal of Thrombosis and Haemostasis 8 (10), 2152-2158, 2010 | 174 | 2010 |
| Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery KM Musallam, FR Rosendaal, G Zaatari, A Soweid, JJ Hoballah, PM Sfeir, ... JAMA surgery 148 (8), 755-762, 2013 | 170 | 2013 |
| Age‐related complications in treatment‐naive patients with thalassaemia intermedia AT Taher, KM Musallam, A El‐Beshlawy, M Karimi, S Daar, K Belhoul, ... British journal of haematology 150 (4), 486-489, 2010 | 160 | 2010 |
| Iron overload in non-transfusion-dependent thalassemia: a clinical perspective KM Musallam, MD Cappellini, JC Wood, AT Taher Blood reviews 26, S16-S19, 2012 | 149 | 2012 |
| Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major KM Belhoul, ML Bakir, MSE Saned, AMA Kadhim, KM Musallam, ... Annals of hematology 91, 1107-1114, 2012 | 147 | 2012 |
| Iron deficiency beyond erythropoiesis: should we be concerned? KM Musallam, AT Taher Current medical research and opinion 34 (1), 81-93, 2018 | 138 | 2018 |
| Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura LA Lotta, HM Wu, IJ Mackie, M Noris, A Veyradier, MA Scully, G Remuzzi, ... Blood, The Journal of the American Society of Hematology 120 (2), 440-448, 2012 | 134 | 2012 |
